Quotient Investors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Quotient Investors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,981	Closed	-$419K	–	227
2015 Q4	$419K	Sell	2,981 -5,000	-63%	-$693K	0.16%	140
2015 Q3	$1.06M	Sell	7,981 -1,509	-16%	-$260K	0.23%	84
2015 Q2	$1.67M	Buy	+9,490	New	+$1.7M	0.23%	98
2014 Q3	–	Sell	-13,700	Closed	-$2.01M	–	266
2014 Q2	$2.01M	Sell	13,700 -26,539	-66%	-$3.68M	0.44%	72
2014 Q1	$5.58M	Sell	40,239 -35,515	-47%	-$5.35M	1.27%	15
2013 Q4	$9.59M	Buy	75,754 +21,171	+39%	+$2.19M	2.25%	1
2013 Q3	$5.02M	Buy	54,583 +41,870	+329%	+$3.38M	1.31%	13
2013 Q2	$874K	Buy	+12,713	New	+$777K	0.25%	126

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Quotient Investors's JAZZ Position: Q1 2016 in Review

Quotient Investors sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2016, closing a stake of 2,981 shares — an estimated $419K sold.

Quotient Investors first reported a position in JAZZ in Q2 2013 and held it in 8 quarters. The position peaked at $9.59M in Q4 2013. 340 funds tracked by Wall St. Rank hold JAZZ as of Q1 2016.

Quotient Investors reported no remaining Jazz Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Quotient Investors sold 2,981 Jazz Pharmaceuticals shares in Q1 2016, an estimated $419K.
Quotient Investors first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Quotient Investors's Jazz Pharmaceuticals position peaked at $9.59M in Q4 2013.
340 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2016.

Based on Quotient Investors's 13F filing for Q1 2016, filed 14 Apr 2016.